IRMD — what changed in the latest 10-Q

Text added vs the prior filing · source: 10-Q · 2026-07-31

• For the quarter ended June 30, 2026, our revenue increased by $0.1 million, or 0.5%, to $20.5 million from $20.4 million compared to the same period of 2025. Income before the provision for income taxes was $6.9 million for the quarter ended June 30, 2026, compared to $7.3 million for the quarter en…

• MRI Compatible Patient Vital Signs Monitoring Systems6,665 5,944 13,772 12,489

• Amortization of extended maintenance agreements758 592 1,417 1,153

• For the three months ended June 30, 2026, total revenue increased by $0.1 million, or 0.5%, to $20.5 million from $20.4 million for the same period in 2025. This increase is primarily attributed to modifications to our sales incentive plan for patient vital signs monitoring systems, disposables, and…

• Revenue from sales in the U.S. decreased by $1.5 million, or 8%, to $16.7 million for the three months ended June 30, 2026, from $18.2 million for the same period in 2025. Revenue from sales internationally increased by $1.5 million, or 69%, to $3.7 million from $2.2 million for the same period in 2…

Text removed vs the prior filing · source: 10-Q · 2026-05-01

• For the quarter ended March 31, 2026, our revenue increased by $2.5 million, or 13% to $22.0 million, compared to $19.5 million for the quarter ended March 31, 2025. Income before the provision for income taxes was $7.8 million for the quarter ended March 31, 2026, compared to $5.9 million for the q…

• Comparison of the Three Months Ended March 31, 2026 and 2025

• MRI Compatible Intravenous ("IV") Infusion Pump Systems$7,664 $5,999

• MRI Compatible Patient Vital Signs Monitoring Systems7,107 6,545

• For the three months ended March 31, 2026, total revenue increased by $2.5 million, or 13%, to $22.0 million from $19.5 million for the same period in 2025. This increase is primarily attributed to continued demand for our IV infusion pump systems, amortization of extended maintenance revenue, and m…

Text added vs the prior filing · source: 10-Q · 2026-07-31

• •our primary reliance on a limited number of products and our ability to identify and pursue development of additional products;

• •difficulties or delays in the development, production, manufacturing and marketing of new or existing products and services;

• •the impact on our operations and financial results of any public health emergency, including any potential future pandemic or epidemic, or any natural disaster, and any related policies and actions by governments or other third parties;

• •geopolitical risks, including international conflicts, political instability and recent or upcoming elections in the United States (the “U.S.”) and other countries, which could, among other things, lead to increased market volatility;

• •the impact of tariffs, trade restrictions, export controls, and changes in trade policy, which could increase the cost of components and raw materials used in our products, disrupt our supply chain, limit our ability to sell products in international markets, or otherwise adversely affect our busin…

Text removed vs the prior filing · source: 10-Q · 2026-05-01

• •failure to obtain and/or maintain regulatory approvals and comply with applicable regulations;

• •our ability to identify and pursue development of additional products;

• •difficulties or delays in the development, production, manufacturing and marketing of new or existing products and services, including difficulties or delays associated with obtaining requisite regulatory approvals or clearances associated with those activities;

• •potential negative impacts resulting from a future pandemic or epidemic, or natural disaster;

• •the impact on our operations and financial results of any public health emergency and any related policies and actions by governments or other third parties;

Text added vs the prior filing · source: 10-Q · 2026-07-31

• •our primary reliance on a limited number of products and our ability to identify and pursue development of additional products;

• •difficulties or delays in the development, production, manufacturing and marketing of new or existing products and services;

• •the impact on our operations and financial results of any public health emergency, including any potential future pandemic or epidemic, or any natural disaster, and any related policies and actions by governments or other third parties;

• •geopolitical risks, including international conflicts, political instability and recent or upcoming elections in the United States (the “U.S.”) and other countries, which could, among other things, lead to increased market volatility;

• •the impact of tariffs, trade restrictions, export controls, and changes in trade policy, which could increase the cost of components and raw materials used in our products, disrupt our supply chain, limit our ability to sell products in international markets, or otherwise adversely affect our busin…

Text removed vs the prior filing · source: 10-Q · 2026-05-01

• •failure to obtain and/or maintain regulatory approvals and comply with applicable regulations;

• •our ability to identify and pursue development of additional products;

• •difficulties or delays in the development, production, manufacturing and marketing of new or existing products and services, including difficulties or delays associated with obtaining requisite regulatory approvals or clearances associated with those activities;

• •potential negative impacts resulting from a future pandemic or epidemic, or natural disaster;

• •the impact on our operations and financial results of any public health emergency and any related policies and actions by governments or other third parties;

Text added vs the prior filing · source: 10-Q · 2026-07-31

• •our primary reliance on a limited number of products and our ability to identify and pursue development of additional products;

• •difficulties or delays in the development, production, manufacturing and marketing of new or existing products and services;

• •the impact on our operations and financial results of any public health emergency, including any potential future pandemic or epidemic, or any natural disaster, and any related policies and actions by governments or other third parties;

• •geopolitical risks, including international conflicts, political instability and recent or upcoming elections in the United States (the “U.S.”) and other countries, which could, among other things, lead to increased market volatility;

• •the impact of tariffs, trade restrictions, export controls, and changes in trade policy, which could increase the cost of components and raw materials used in our products, disrupt our supply chain, limit our ability to sell products in international markets, or otherwise adversely affect our busin…

Text removed vs the prior filing · source: 10-Q · 2026-05-01

• •failure to obtain and/or maintain regulatory approvals and comply with applicable regulations;

• •our ability to identify and pursue development of additional products;

• •difficulties or delays in the development, production, manufacturing and marketing of new or existing products and services, including difficulties or delays associated with obtaining requisite regulatory approvals or clearances associated with those activities;

• •potential negative impacts resulting from a future pandemic or epidemic, or natural disaster;

• •the impact on our operations and financial results of any public health emergency and any related policies and actions by governments or other third parties;

Text added vs the prior filing · source: 10-Q · 2026-07-31

• •our primary reliance on a limited number of products and our ability to identify and pursue development of additional products;

• •difficulties or delays in the development, production, manufacturing and marketing of new or existing products and services;

• •the impact on our operations and financial results of any public health emergency, including any potential future pandemic or epidemic, or any natural disaster, and any related policies and actions by governments or other third parties;

• •geopolitical risks, including international conflicts, political instability and recent or upcoming elections in the United States (the “U.S.”) and other countries, which could, among other things, lead to increased market volatility;

• •the impact of tariffs, trade restrictions, export controls, and changes in trade policy, which could increase the cost of components and raw materials used in our products, disrupt our supply chain, limit our ability to sell products in international markets, or otherwise adversely affect our busin…

Text removed vs the prior filing · source: 10-Q · 2026-05-01

• •failure to obtain and/or maintain regulatory approvals and comply with applicable regulations;

• •our ability to identify and pursue development of additional products;

• •difficulties or delays in the development, production, manufacturing and marketing of new or existing products and services, including difficulties or delays associated with obtaining requisite regulatory approvals or clearances associated with those activities;

• •potential negative impacts resulting from a future pandemic or epidemic, or natural disaster;

• •the impact on our operations and financial results of any public health emergency and any related policies and actions by governments or other third parties;

Text added vs the prior filing · source: 10-Q · 2026-07-31

• •our primary reliance on a limited number of products and our ability to identify and pursue development of additional products;

• •difficulties or delays in the development, production, manufacturing and marketing of new or existing products and services;

• •the impact on our operations and financial results of any public health emergency, including any potential future pandemic or epidemic, or any natural disaster, and any related policies and actions by governments or other third parties;

• •geopolitical risks, including international conflicts, political instability and recent or upcoming elections in the United States (the “U.S.”) and other countries, which could, among other things, lead to increased market volatility;

• •the impact of tariffs, trade restrictions, export controls, and changes in trade policy, which could increase the cost of components and raw materials used in our products, disrupt our supply chain, limit our ability to sell products in international markets, or otherwise adversely affect our busin…

Text removed vs the prior filing · source: 10-Q · 2026-05-01

• •failure to obtain and/or maintain regulatory approvals and comply with applicable regulations;

• •our ability to identify and pursue development of additional products;

• •difficulties or delays in the development, production, manufacturing and marketing of new or existing products and services, including difficulties or delays associated with obtaining requisite regulatory approvals or clearances associated with those activities;

• •potential negative impacts resulting from a future pandemic or epidemic, or natural disaster;

• •the impact on our operations and financial results of any public health emergency and any related policies and actions by governments or other third parties;